Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma-Reference-Cited by-同舟云学术

Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma

Published:2010-03-09 Issue:3 Volume:91 Page:426-435
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Asano Naoko,Suzuki Ritsuro,Ohshima Koichi,Kagami Yoshitoyo,Ishida Fumihiro,Yoshino Tadashi,Ogawa Hiroshi,Morishima Yasuo,Nakamura Shigeo

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-010-0513-0.pdf

Reference39 articles.

1. Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of lymphomas: a work in progress. Ann Oncol. 1998;9:S25–30.

2. Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2008.

3. Lymphoma study group of Japanese pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000;50:696–702.

4. Ichimura K, Kagami Y, Suzuki R, et al. Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites. Pathol Int. 2003;53:333–44.

5. ten Berge RL, de Bruin PC, Oudejans JJ, Ossenkoppele GJ, van der Valk P, Meijer CJ. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. Histopathology. 2003;43:462–9.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological implications of immunohistochemical expression of TBX21, CXCR3, GATA3, CCR4, and TCF1 in nodal follicular helper T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified;Journal of Pathology and Translational Medicine;2024-03-15

2. Effect of proteasome inhibitors on canine lymphoma cell response to CHOP chemotherapy in vitro;Veterinary and Comparative Oncology;2024-01-18

3. PD-1 blockade combined with decitabine to treat refractory peripheral T-cell lymphoma not otherwise specified: A case report and review of literature;Journal of Cancer Research and Therapeutics;2023-12

4. Role of chemokines in T-cell acute lymphoblastic Leukemia: From pathogenesis to therapeutic options;International Immunopharmacology;2023-08

5. Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma;Blood Advances;2023-07-12